PCK2 and colonic neoplasm: These DEGs, significantly altered in human colon cancer tissue (TCGA) (Supplemental S4), are ones with both emerging roles (SEC24D, ABCC3, ATGL2B, and PCK2) and established roles (MYC and MUC2) in colonic tumorigenesis.